MediPharm Labs - CEO, Bryan Howcroft
CEO, Bryan Howcroft
Source: LinkedIn
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • MediPharm Labs (LABS) has completed a medical cannabis export to Barbados in conjunction with partner Avicanna
  • The company has manufactured and delivered Avicanna RHO Phyto products for the medical community and patients in the Caribbean
  • MediPharm is the only North American producer with a Drug Establishment License (GMP) for the extraction of natural cannabinoids
  • MediPharm Labs formulates, processes, packages and distributes cannabis extracts and cannabinoid-based products to domestic and international markets
  • MediPharm Labs Corp. (LABS) opened trading at C$0.225 per share

MediPharm Labs (LABS) has completed a medical cannabis export to Barbados in conjunction with partner Avicanna (TSX: AVCN).

“Our GMP platform make us the go-to partner for companies looking to access global medical cannabis programs,” said Bryan Howcroft, CEO, MediPharm Labs.

“As countries around the world continue to adopt medical cannabis programs, MediPharm Labs is best positioned to serve these markets as the only North American producer with a Drug Establishment License (GMP) for the extraction of natural cannabinoids.”

The company has manufactured and delivered Avicanna RHO Phyto products for the medical community and patients in the Caribbean through Bryden Stokes, an established health and pharmaceutical product distributor in the region.

These advanced cannabis products are marketed via the Avicanna educational platform, including patient support, marketing, and training.

MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms.

Through its wholesale and white label platforms, MediPharm Labs formulates, processes, packages and distributes cannabis extracts and cannabinoid-based products to domestic and international markets.

MediPharm Labs Corp. (LABS) opened trading at C$0.225 per share.

More From The Market Herald

" BioHarvest (CSE:BHSC) predicts 2022 revenue to grow up to 3.5 times

BioHarvest Sciences Inc. (BHSC) expects strong revenue growth to continue in 2022 due to a successful over-delivery of projected revenue targets from last year.

" Icanic Brands (CSE:ICAN) agrees to acquire cannabis extraction company

Icanic Brands Company (ICAN) has signed a definitive agreement to acquire 100 per cent of LEEF Holdings Inc.
Tilray - Denise Faltischek, Head of International and Chief Strategy Officer.

" Tilray (TSX:TLRY) expands Australian medical cannabis offering

Tilray (TLRY) has expanded its medical cannabis product suite in Australia.

" Craftport Cannabis (CSE:CFT) announces $3M private placement

Craftport Cannabis (CFT) has announced a non-brokered private placement for gross proceeds of $3 million.